Cellid Co

Cellid Co Dividend Yield

Dividend Yield of Cellid Co (299660.KQ) as of Oct 17, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of Cellid Co is 2026 - . Dividend Yield of Cellid Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cellid Co Stock analysis

What does Cellid Co do? Cellid Co Ltd, based in Seoul, South Korea, operates in the Health Care sector within the Biotechnology industry. The company develops immunotherapeutic vaccines, focusing on cancer therapeutic vaccines through its BVAC pipeline products using CeliVax technology. Listed on 20 February 2019, Cellid employs 59 full-time staff and conducts clinical research to advance its vaccine development. Cellid Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellid Co stock

On Eulerpool you can find the complete historical development of Dividend Yield Cellid Co since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Cellid Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Cellid Co

All Key Metrics — Cellid Co